BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36216889)

  • 1. The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations.
    Stalbow LA; Preuss MH; Smit RAJ; Chami N; Bjørkhaug L; Aukrust I; Gloyn AL; Loos RJF
    Diabetologia; 2023 Jan; 66(1):116-126. PubMed ID: 36216889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ancestry effects on type 2 diabetes genetic risk inference in Hispanic/Latino populations.
    Chande AT; Rishishwar L; Conley AB; Valderrama-Aguirre A; Medina-Rivas MA; Jordan IK
    BMC Med Genet; 2020 Jun; 21(Suppl 2):132. PubMed ID: 32580712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic risk variants for type 2 diabetes susceptibility modify age at diagnosis in monogenic HNF1A diabetes.
    Lango Allen H; Johansson S; Ellard S; Shields B; Hertel JK; Raeder H; Colclough K; Molven A; Frayling TM; Njølstad PR; Hattersley AT; Weedon MN
    Diabetes; 2010 Jan; 59(1):266-71. PubMed ID: 19794065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide polygenic risk score for retinopathy of type 2 diabetes.
    Forrest IS; Chaudhary K; Paranjpe I; Vy HMT; Marquez-Luna C; Rocheleau G; Saha A; Chan L; Van Vleck T; Loos RJF; Cho J; Pasquale LR; Nadkarni GN; Do R
    Hum Mol Genet; 2021 May; 30(10):952-960. PubMed ID: 33704450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations.
    Ge T; Irvin MR; Patki A; Srinivasasainagendra V; Lin YF; Tiwari HK; Armstrong ND; Benoit B; Chen CY; Choi KW; Cimino JJ; Davis BH; Dikilitas O; Etheridge B; Feng YA; Gainer V; Huang H; Jarvik GP; Kachulis C; Kenny EE; Khan A; Kiryluk K; Kottyan L; Kullo IJ; Lange C; Lennon N; Leong A; Malolepsza E; Miles AD; Murphy S; Namjou B; Narayan R; O'Connor MJ; Pacheco JA; Perez E; Rasmussen-Torvik LJ; Rosenthal EA; Schaid D; Stamou M; Udler MS; Wei WQ; Weiss ST; Ng MCY; Smoller JW; Lebo MS; Meigs JB; Limdi NA; Karlson EW
    Genome Med; 2022 Jun; 14(1):70. PubMed ID: 35765100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes.
    Huerta-Chagoya A; Schroeder P; Mandla R; Deutsch AJ; Zhu W; Petty L; Yi X; Cole JB; Udler MS; Dornbos P; Porneala B; DiCorpo D; Liu CT; Li JH; Szczerbiński L; Kaur V; Kim J; Lu Y; Martin A; Eizirik DL; Marchetti P; Marselli L; Chen L; Srinivasan S; Todd J; Flannick J; Gubitosi-Klug R; Levitsky L; Shah R; Kelsey M; Burke B; Dabelea DM; Divers J; Marcovina S; Stalbow L; Loos RJF; Darst BF; Kooperberg C; Raffield LM; Haiman C; Sun Q; McCormick JB; Fisher-Hoch SP; Ordoñez ML; Meigs J; Baier LJ; González-Villalpando C; González-Villalpando ME; Orozco L; García-García L; Moreno-Estrada A; ; Aguilar-Salinas CA; Tusié T; Dupuis J; Ng MCY; Manning A; Highland HM; Cnop M; Hanson R; Below J; Florez JC; Leong A; Mercader JM
    Diabetologia; 2023 Jul; 66(7):1273-1288. PubMed ID: 37148359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population.
    ; Estrada K; Aukrust I; Bjørkhaug L; Burtt NP; Mercader JM; García-Ortiz H; Huerta-Chagoya A; Moreno-Macías H; Walford G; Flannick J; Williams AL; Gómez-Vázquez MJ; Fernandez-Lopez JC; Martínez-Hernández A; Jiménez-Morales S; Centeno-Cruz F; Mendoza-Caamal E; Revilla-Monsalve C; Islas-Andrade S; Córdova EJ; Soberón X; González-Villalpando ME; Henderson E; Wilkens LR; Le Marchand L; Arellano-Campos O; Ordóñez-Sánchez ML; Rodríguez-Torres M; Rodríguez-Guillén R; Riba L; Najmi LA; Jacobs SB; Fennell T; Gabriel S; Fontanillas P; Hanis CL; Lehman DM; Jenkinson CP; Abboud HE; Bell GI; Cortes ML; Boehnke M; González-Villalpando C; Orozco L; Haiman CA; Tusié-Luna T; Aguilar-Salinas CA; Altshuler D; Njølstad PR; Florez JC; MacArthur DG
    JAMA; 2014 Jun; 311(22):2305-14. PubMed ID: 24915262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsupervised Clustering of Missense Variants in HNF1A Using Multidimensional Functional Data Aids Clinical Interpretation.
    Althari S; Najmi LA; Bennett AJ; Aukrust I; Rundle JK; Colclough K; Molnes J; Kaci A; Nawaz S; van der Lugt T; Hassanali N; Mahajan A; Molven A; Ellard S; McCarthy MI; Bjørkhaug L; Njølstad PR; Gloyn AL
    Am J Hum Genet; 2020 Oct; 107(4):670-682. PubMed ID: 32910913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
    Jafar-Mohammadi B; Groves CJ; Owen KR; Frayling TM; Hattersley AT; McCarthy MI; Gloyn AL
    PLoS One; 2009 Aug; 4(8):e6615. PubMed ID: 19672314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the trans-ancestry polygenic risk score on type 2 diabetes risk, onset age and progression among population in Taiwan.
    Wang SH; Huang YC; Cheng CW; Chang YW; Liao WL
    Am J Physiol Endocrinol Metab; 2024 May; 326(5):E547-E554. PubMed ID: 38363735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Analyses of HNF1A-MODY Variants Refine the Interpretation of Identified Sequence Variants.
    Malikova J; Kaci A; Dusatkova P; Aukrust I; Torsvik J; Vesela K; Kankova PD; Njølstad PR; Pruhova S; Bjørkhaug L
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32017842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY.
    Kettunen JLT; Rantala E; Dwivedi OP; Isomaa B; Sarelin L; Kokko P; Hakaste L; Miettinen PJ; Groop LC; Tuomi T
    Diabetologia; 2022 Apr; 65(4):632-643. PubMed ID: 34951657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Investigations of HNF1A Identify Rare Variants as Risk Factors for Type 2 Diabetes in the General Population.
    Najmi LA; Aukrust I; Flannick J; Molnes J; Burtt N; Molven A; Groop L; Altshuler D; Johansson S; Bjørkhaug L; Njølstad PR
    Diabetes; 2017 Feb; 66(2):335-346. PubMed ID: 27899486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalizability of Polygenic Risk Scores for Breast Cancer Among Women With European, African, and Latinx Ancestry.
    Liu C; Zeinomar N; Chung WK; Kiryluk K; Gharavi AG; Hripcsak G; Crew KD; Shang N; Khan A; Fasel D; Manolio TA; Jarvik GP; Rowley R; Justice AE; Rahm AK; Fullerton SM; Smoller JW; Larson EB; Crane PK; Dikilitas O; Wiesner GL; Bick AG; Terry MB; Weng C
    JAMA Netw Open; 2021 Aug; 4(8):e2119084. PubMed ID: 34347061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying factors that affect polygenic risk score performance across diverse ancestries and age groups for body mass index.
    Hui D; Xiao B; Dikilitas O; Freimuth RR; Irvin MR; Jarvik GP; Kottyan L; Kullo I; Limdi NA; Liu C; Luo Y; Namjou B; Puckelwartz MJ; Schaid D; Tiwari H; Wei WQ; Verma S; Kim D; Ritchie MD
    Pac Symp Biocomput; 2023; 28():437-448. PubMed ID: 36540998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Common
    Locke JM; Saint-Martin C; Laver TW; Patel KA; Wood AR; Sharp SA; Ellard S; Bellanné-Chantelot C; Hattersley AT; Harries LW; Weedon MN
    Diabetes; 2018 Sep; 67(9):1903-1907. PubMed ID: 29895593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Value of Rare Genetic Variation in the Prediction of Common Obesity in European Ancestry Populations.
    Wang Z; Choi SW; Chami N; Boerwinkle E; Fornage M; Redline S; Bis JC; Brody JA; Psaty BM; Kim W; McDonald MN; Regan EA; Silverman EK; Liu CT; Vasan RS; Kalyani RR; Mathias RA; Yanek LR; Arnett DK; Justice AE; North KE; Kaplan R; Heckbert SR; de Andrade M; Guo X; Lange LA; Rich SS; Rotter JI; Ellinor PT; Lubitz SA; Blangero J; Shoemaker MB; Darbar D; Gladwin MT; Albert CM; Chasman DI; Jackson RD; Kooperberg C; Reiner AP; O'Reilly PF; Loos RJF
    Front Endocrinol (Lausanne); 2022; 13():863893. PubMed ID: 35592775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study.
    Ley SH; Hegele RA; Harris SB; Mamakeesick M; Cao H; Connelly PW; Gittelsohn J; Retnakaran R; Zinman B; Hanley AJ
    BMC Med Genet; 2011 Jan; 12():1. PubMed ID: 21208426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: a population-based epidemiological study.
    Ley SH; Hegele RA; Connelly PW; Harris SB; Mamakeesick M; Cao H; Gittelsohn J; Retnakaran R; Zinman B; Hanley AJ
    Cardiovasc Diabetol; 2010 Aug; 9():39. PubMed ID: 20716378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.